Thiboutot DM, Weiss J, Bucko A, et al
However, Ozempic is not FDA-approved for treating high blood pressure as a standalone condition it is approved for type 2 diabetes management and cardiovascular risk reduction
Beginning the Treatment GLP-1 injections are typically started at a lower dose to minimize side effects, then gradually increased
If approved, elecoglipron could become the third major oral GLP-1 option targeting obesity, joining Novo Nordisk's oral semaglutide (often referred to as Oral Wegovy) and Eli Lilly's investigational orforglipron, which recently received the brand name Foundayo
For instance, PLGA microspheres containing GLP-1 analogs can sustain drug release over days to weeks [125]
In addition, a uniform and statistically significant reduction in ALT, as a marker of hepatocyte damage, was observed in all combination groups 59